Snake venom modulators of platelet adhesion receptors and their ligands

Toxicon

Volumn 38, Issue 6, 2000, Pages 775-791

  Andrews, Robert K ^a   Berndt, Michael C ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; DISINTEGRIN; INTEGRIN; METALLOPROTEINASE; SNAKE VENOM; THROMBIN RECEPTOR; THROMBOCYTE RECEPTOR; VON WILLEBRAND FACTOR;

ARTICLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; STRUCTURE ACTIVITY RELATION; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOSIS;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD36; HUMANS; LIGANDS; MOLECULAR SEQUENCE DATA; PLATELET ADHESIVENESS; RECEPTORS, CYTOADHESIN; RECEPTORS, THROMBIN; SNAKE VENOMS; STRUCTURE-ACTIVITY RELATIONSHIP; VON WILLEBRAND FACTOR;

SERPENTES;

EID: 0033980343     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-0101(99)00187-7     Document Type: Article

References (64)

1. Andrews R.K., Berndt M.C. Adhesion-dependent signalling and the initiation of haemostasis and thrombosis. Histol. Histopath. 13:1998;837-844.
2. Andrews R.K., López J.A., Berndt M.C. Molecular mechanisms of platelet adhesion and activation. Int. J. Biochem. Cell Biol. 29:1997;91-105.
3. Andrews R.K., Booth W.J., Gorman J.J., Castaldi P.A., Berndt M.C. Purification of botrocetin from Bothrops jararaca venom. Analysis of the botrocetin-mediated interaction between von Willebrand factor and the human platelet membrane glycoprotein Ib-IX complex. Biochemistry. 28:1989;8317-8326.
4. Andrews R.K., Kroll M.H., Ward C.M., Rose J.W., Scarborough R.M., Smith A.I., López J.A., Berndt M.C. Binding of a novel 50-kilodalton alboaggregin from Trimeresurus albolabris and related viper venom proteins to the platelet membrane glycoprotein Ib-IV-V complex. Effect on platelet aggregation and glycoprotein Ib-mediated platelet activation. Biochemistry. 35:1996;12629-12639.
5. Berndt M.C., Ward C.M., Booth W.J., Castaldi P.A., Mazurov A.V., Andrews R.K. Identification of aspartic acid 514 through glutamic acid 542 as a glycoprotein Ib-IX complex receptor recognition sequence in von willebrand factor. Mechanism of modulation of von Willebrand Factor by ristocetin and botrocetin. Biochemistry. 31:1992;11144-11151.
6. Bjarnason J.B., Fox J.W. Hemorrhagic metalloproteinases from snake venoms. Pharmac. Ther. 62:1994;325-372.
7. Black R.A., Rauch C.T., Kozlosky C.J., Peschon J.J., Slack J.L., Wolfson M.F., Castner B.J., Stocking K.L., Reddy P., Srinivasan S., Nelson N., Boiani N., Schooley K.A., Gerhart M., Davis R., Fitzner J.N., Johnson R.S., Paxton R.J., March C.J., Cerretti D.P. A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells. Nature. 385:1997;729-733.
8. Chang M.C., Lin H.K., Peng H.C., Huang T.F. Antithrombotic effect of crotalin, a platelet membrane glycoprotein Ib antagonist from venom of Crotalus atrox. Blood. 91:1998;1582-1589.
9. Chen Y.L., Tsai I.H. Functional and sequence characterization of agkicetin, a new glycoprotein Ib antagonist isolated from Agkistrodon acutus venom. Biochem. Biophys. Res. Commun. 210:1995;472-477.
10. De Luca M., Ward C.M., Ohmori K., Andrews R.K., Berndt M.C. Jararhagin and jaracetin: novel snake venom inhibitors of the integrin collagen receptor, α2β1. Biochem. Biophys. Res. Commun. 206:1995;570-576.
11. De Luca M., Dunlop L.C., Andrews R.K., Flannery J.V. Jr, Ettling R., Cumming D.A., Veldman G.M., Berndt M.C. A novel cobra venom metalloproteinase, mocarhagin, cleaves a 10-amino acid peptide from the mature N terminus of P-selectin glycoprotein ligand receptor, PSGL-1, and abolishes P-selectin binding. J. Biol. Chem. 270:1995;26734-26737.
12. Dong J-F., Li C.Q., López J.A. Tyrosine sulfation of the glycoprotein Ib-IX complex: Identification of sulfated residues and effect on ligand binding. Biochemistry. 33:1994;13946-13953.
13. 3 and platelet function. Thromb. Haemostas. 78:1997;96-100.
14. Fujimura Y., Kawasaki T., Titani K. Snake venom proteins modulating the interaction between von Willebrand factor and platelet glycoprotein Ib. Thromb. Haemostas. 76:1996;633-639.
15. Fujimura Y., Titani K., Usami Y., Suzuki M., Oyama R., Matsui T., Fukui H., Sugimoto M., Ruggeri Z.M. Isolation and chemical characterization of two structurally and functionally distinct forms of botrocetin, the platelet coagglutinin isolated from the venom of Bothrops jararaca. Biochemistry. 30:1991;1957-1964.
16. Fujimura Y., Ikeda Y., Miura S., Yoshida E., Shima H., Nishida S., Suzuki M., Titani K., Taniuchi Y., Kawasaki T. Isolation and characterization of jararaca GPIb-BP, a snake venom antagonist specific to platelet glycoprotein Ib. Thromb. Haemostas. 74:1995;743-750.
17. Gomis-Ruth F-X., Kress L.F., Bode W. First structure of a snake venom metalloproteinase: a prototype for matrix metalloproteinases/collagenases. Embo J. 12:1993;4151-4157.
18. Hamako J., Matsui T., Nishida S., Nomura S., Fujimura Y., Ito M., Ozeki Y., Titani K. Purification and characterization of kaouthiagin, a von Willebrand factor-binding and -cleaving metalloproteinase from Naja kaouthia cobra venom. Thromb. Haemostas. 80:1998;499-505.
19. Howard L., Lu X., Mitchell S., Griffiths S., Glynn P. Molecular cloning of MADM: a catalytically active mammalian disintegrin-metalloprotease expressed in various cell types. Biochem. J. 317:1996;45-50.
20. Hutton R.A., Warrell D.A. Action of snake venom components on the haemostatic system. Blood reviews. 7:1993;176-189.
21. Ivaska J., Kapyla J., Pentikainen O., Hoffren A.M., Hermonen J., Huttunen P., Heino J. A peptide inhibiting the collagen binding function of integrin α2 I domain. J. Biol. Chem. 274:1999;3513-3521.
22. Jandrot-Perrus M., Lagrue A.H., Okuma M., Bon C. Adhesion and activation of human platelets induced by convulxin involve glycoprotein VIi and integrin α2β1. J. Biol. Chem. 272:1997;27035-27041.
23. Jia L.G., Shimokawa K., Bjarnason J.B., Fox J.W. Snake venom metalloproteinases: structure, function and relationship to the ADAMs family of proteins. Toxicon. 34:1996;1269-1276.
24. Jia L.G., Wang X.M., Shannon J.D., Bjarnason J.B., Fox J.W. Function of disintegrin-like/cysteine-rich domains of atrolysin A. Inhibition of platelet aggregation by recombinant protein and peptide antagonists. J. Biol. Chem. 272:1997;13094-13102.
25. Kamata T., Takada Y. Direct binding of collagen to the I domain of integrin α2β1 (VLA-2, CD49b/CD29) in a divalent cation-independent manner. J. Biol. Chem. 269:1994;26006-26010.
26. Kamiguti A.S., Hay C.R.M., Zuzel M. Inhibition of collagen-induced platelet aggregation as the result of cleavage of α2β1-integrin by the snake venom metalloproteinase jararhagin. Biochem. J. 320:1996;635-641.
27. Kamiguti A.S., Markland F.S., Zhou Q., Laing G.D., Theakston R.D., Zuzel M. Proteolytic cleavage of the β1 subunit of platelet α2β1 integrin by the metalloproteinase jararhagin compromises collagen-stimulated phosphorylation of pp72. J. Biol. Chem. 272:1997;32599-32605.
28. Kawasaki T., Taniuchi Y., Hisamichi N., Fujimura Y., Suzuki M., Titani K., Kaku S., Satoh N., Takenaka T., Handa M., Sawai Y. Tokaracetin, a new platelet antagonist that binds to platelet glycoprotein Ib and inhibits von Willebrand factor-dependent shear-induced platelet aggregation. Biochem. J. 308:1995;947-953.
29. Kini R.M. Are C-type lectin-related proteins derived by proteolysis of metalloproteinase/disintegrin precursor proteins? Toxicon. 34:1996;1287-1294.
30. Kini R.M., Evans H.J. Structural domains in venom proteins: evidence that metalloproteinases and nonenzymatic platelet aggregation inhibitors (disintegrins) from snake venoms are derived by proteolysis from a common precursor. Toxicon. 30:1992;265-293.
31. Kowalska M.A., Tan L., Holt J.C., Peng M., Karczewski J., Calvete J.J., Niewiarowski S. Alboaggregins A and B. Structure and interaction with human platelets. Thromb. Haemostas. 79:1998;609-613.
32. Kratzschmar J., Lum L., Blobel C.P. Metargidin, a membrane-anchored metalloprotease-disintegrin protein with an RGD integrin binding sequence. J. Biol. Chem. 271:1996;4593-4596.
33. Kroll M.H., Hellums J.D., McIntyre L.V., Schafer A.I., Moake J.L. Platelets and shear stress. Blood. 88:1996;1525-1541.
34. López J.A. The platelet of glycoprotein Ib-IX complex. Blood Coag. Fibrinol. 5:1994;97-119.
35. McLane M.A., Marcinkiewicz C., Vijay-Kumar S., Wierzbicka-Patynowska I., Niewiarowski S. Viper venom disintegrins and related molecules. Proc. Soc. Exp. Biol. Med. 219:1998;109-119.
36. Marchese P., Murata M., Mazzucato M., Pradella P., de Marco L., Ware J., Ruggeri Z.M. Identification of three tyrosine residues of glycoprotein Ibα with distinct roles in von Willebrand factor and α-thrombin binding. J. Biol. Chem. 270:1995;9571-9578.
37. Maskos K., Fernandez-Catalan C., Huber R., Bourenkov G.P., Bartunik H., Ellestad G.A., Reddy P., Wolfson M.F., Rauch C.T., Castner B.J., Davis R., Clarke H.R., Petersen M., Fitzner J.N., Cerretti D.P., March C.J., Paxton R.J., Black R.A., Bode W. Crystal structure of the catalytic domain of human tumor necrosis factor-α-converting enzyme. Proc. Natl. Acad. Sci. USA. 95:1998;3408-3412.
38. Myles D.G., Kimmel L.H., Blobel C.P., White J.M., Primakoff P. Identification of a binding site in the disintegrin domain of fertilin required for sperm-egg fusion. Proc. Natl. Acad. Sci. USA. 91:1994;4195-4198.
39. Obert B., Houllier A., Meyer D., Girma J-P. Conformational changes in the A3 domain of von Willebrand factor modulate the interaction of the A1 domain with platelet glycoprotein Ib. Blood. 93:1999;1959-1968.
40. Ogilvie M.L., Gartner T.K. Identification of lectins in snake venoms. J. Herpetol. 18:1984;285-290.
41. Paine M.J.I., Desmond H.P., Theakston R.D.G., Crampton J.M. Purification, cloning, and molecular characterization of a high molecular weight hemorrhagic metalloprotease, jararhagin, from Bothrops jararaca venom: insights into the disintegrin gene family. J. Biol. Chem. 267:1992;22869-22876.
42. Peng M., Holt J.C., Niewiarowski S. Isolation, characterization and amino acid sequence of echicetin β subunit, a specific inhibitor to von Willebrand factor and thrombin interaction with glycoprotein Ib. Biochem. Biophys. Res. Commun. 205:1994;68-72.
43. Peng M., Lu W., Kirby E.P. Alboaggregin-B: a new platelet agonist that binds to platelet membrane glycoprotein Ib. Biochemistry. 30:1991;11529-11536.
44. Peng M., Lu W., Kirby E.P. Characterization of three alboaggregins purified from Trimeresurus albolabris venom. Thromb. Haemostas. 67:1992;702-707.
45. Peng M., Lu W., Beviglia L., Niewiarowski S., Kirby E.P. Echicetin: a snake venom protein that inhibits binding of von Willebrand factor and alboaggregins to platelet glycoprotein Ib. Blood. 81:1993;2321-2328.
46. Polgar J., Clemetson J.M., Kehrel B.E., Weidemann M., Magnenat E.M., Wells T.N.C., Clemetson K.J. Platelet activation and signal transduction by convulxin, a C-type lectin from Crotalus durissus terrificus (tropical rattlesnake) venom via the p62/GPVI collagen receptor. J. Biol. Chem. 272:1997;13576-13583.
47. Preece G., Murphy G., Ager A. Metalloproteinase-mediated regulation of L-selectin levels on leucocytes. J. Biol. Chem. 271:1996;11634-11640.
48. Read M.S., Shermer R.W., Brinkhous K.M. Venom coagglutinin: an activator of platelet aggregation dependent on von Willebrand factor. Proc. Natl. Acad. Sci. USA. 83:1978;4514-4518.
49. Read M.S., Smith S.V., Lamb M.A., Brinkhous K.M. Role of botrocetin in platelet agglutination: formation of an activated complex of botrocetin and von Willebrand factor. Blood. 74:1989;1031-1035.
50. Sakurai Y., Fujimura Y., Kokubo T., Imamura K., Kawasaki T., Handa M., Suzuki M., Matsui T., Titani K., Yoshioka A. The cDNA cloning and molecular characterization of a snake venom platelet glycoprotein Ib-binding protein, mamushigin, from Agkistrodon halys blomhoffi venom. Thromb. Haemostas. 79:1998;1199-1207.
51. Shin Y., Morita T. Rhodocytin, a functional novel platelet agonist belonging to the heterodimeric C-type lectin family, induces platelet aggregation independently of glycoprotein Ib. Biochem. Biophys. Res. Commun. 245:1998;741-745.
52. Sugimoto M., Mohri H., McClintock R.A., Ruggeri Z.M. Identification of discontinuous von Willebrand factor sequences involved in complex formation with botrocetin. J. Biol. Chem. 266:1991;18172-18178.
53. Taniuchi Y., Kawasaki T., Fujimura Y., Suzuki M., Titani K., Sakai Y., Kaku S., Hisamichi N., Satoh M., Takenaka T., Handa M., Sawai Y. Flavocetin-A and -B, two high molecular mass glycoprotein Ib binding proteins with high molecular mass glycoprotein Ib binding proteins with high affinity purified from Trimeresurus flavoviridis venom, inhibit platelet aggregation at high shear stress. Biochim. Biophys. Acta. 1244:1995;331-338.
54. Teng C-M., Huang T-F. Inventory of exogenous inhibitors of platelet aggregation. Thromb. Haemostas. 65:1991;624-626.
55. Usami Y., Fujimura Y., Suzuki M., Ozeki Y., Nishio K., Fukui H., Titani K. Primary structure of two-chain botrocetin; a von Willebrand factor modulator purified from the venom of Bothrops jararaca. Proc. Natl. Acad. Sci. USA. 90:1993;928-932.
56. Usami Y., Suzuki M., Yoshida E., Sakurai Y., Hirano K., Kawasaki T., Fujimura Y., Titani K. Primary structure of alboaggregin-B purified from the venom of Trimeresurus albolabris. Biochem. Biophys. Res. Commun. 219:1996;727-733.
57. Usami Y., Fujimura Y., Miura S., Shima H., Yoshida E., Yoshioka A., Hirano K., Suzuki M., Titani K. A 28 kDA-protein with disintegrin-like structure (jararhagin-C) purified from Bothrops jararaca venom inhibits collagen- and ADP-induced platelet aggregation. Biochem. Biophys. Res. Commun. 201:1994;331-339.
58. Ward C.M., Andrews R.K., Smith A.I., Berndt M.C. Mocarhagin, a novel cobra venom metalloproteinase, cleaves the platelet von Willebrand factor receptor glycoprotein Ibα. Identification of the sulfated tyrosine/anionic sequence Tyr-276-Glu-282 of glycoprotein Ibα as a binding site for von Willebrand factor and α-thrombin. Biochemistry. 35:1996;4929-4938.
59. Ward C.M., Vinogradov D.V., Andrews R.K., Berndt M.C. Characterization of mocarhagin, a cobra venom metalloproteinase from Naja mocambique mocambique, and related proteins from other Elapidae venoms. Toxicon. 34:1996;1203-1206.
60. Watson S.P., Gibbins J. Collagen receptor signalling in platelets: extending the role of the ITAM. Immunol. Today. 19:1998;260-264.
61. Weiss H.J. Flow-related platelet deposition on subendothelium. Thromb. Haemostas. 74:1995;117-122.
62. Weskamp G., Kratzschmar J., Reid M.S., Blobel C.P. MDC9, a widely expressed cellular disintegrin containing cytoplasmic SH3 ligand domains. J. Cell Biol. 132:1996;717-726.
63. Wu E., Croucher P.I., McKie N. Expression of members of the novel membrane linked metalloproteinase family ADAM in cells derived from a range of haematological malignancies. Biochem. Biophys. Res. Commun. 235:1997;437-442.
64. Zhou Q., Dangelmaier C., Smith J.B. The hemorrhagin catrocollastatin inhibits collagen-induced platelet aggregation by binding to collagen via its disintegrin-like domain. Biochem. Biophys. Res. Commun. 219:1996;720-726.